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Abstract
Background: Phosphopantetheinyl transferases (PPTases) cata-
lyze the posttranslational modification of carrier proteins by the
covalent attachment of the 4P-phosphopantetheine (P-pant)
moiety of coenzyme A to a conserved serine residue, a reaction
absolutely required for the biosynthesis of natural products
including fatty acids, polyketides, and nonribosomal peptides.
PPTases have been classified according to their carrier protein
specificity. In organisms containing multiple P-pant-requiring
pathways, each pathway has been suggested to have its own
PPTase activity. However, sequence analysis of the bleomycin
biosynthetic gene cluster in Streptomyces verticillus ATCC15003
failed to reveal an associated PPTase gene.
Results : A general approach for cloning PPTase genes by PCR
was developed and applied to the cloning of the svp gene from S.
verticillus. The svp gene is mapped to an independent locus not
clustered with any of the known NRPS or PKS clusters. The Svp
protein was overproduced in Escherichia coli, purified to homo-
geneity, and shown to be a monomer in solution. Svp is a PPTase
capable of modifying both type I and type II acyl carrier proteins
(ACPs) and peptidyl carrier proteins (PCPs) from either
S. verticillus or other Streptomyces species. As compared to Sfp,
the only ‘promiscuous’ PPTase known previously, Svp displays a
similar catalytic efficiency (kcat/Km) for the BlmI PCP but a 346-
fold increase in catalytic efficiency for the TcmM ACP.
Conclusions: PPTases have recently been re-classified on a
structural basis into two subfamilies : ACPS-type and Sfp-type.
The development of a PCR method for cloning Sfp-type PPTases
from actinomycetes, the recognition of the Sfp-type PPTases to be
associated with secondary metabolism with a relaxed carrier
protein specificity, and the availability of Svp, in addition to Sfp,
should facilitate future endeavors in engineered biosynthesis of
peptide, polyketide, and, in particular, hybrid peptide^polyketide
natural products. ß 2001 Elsevier Science Ltd. All rights re-
served.
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1. Introduction
Fatty acid synthases (FASs), polyketide synthases
(PKSs), and nonribosomal peptide synthetases (NRPSs)
all contain one or more small proteins, either as integrated
domains (type I) or as discrete subunits (type II), that
function as carrier proteins for the growing intermediate
in the biosynthesis of fatty acids, polyketides, and non-
ribosomal peptides. Depending on the nature of the grow-
ing intermediate, these carrier proteins are called acyl car-
rier proteins (ACPs), aryl carrier proteins (ArCPs), or
peptidyl carrier proteins (PCPs). Carrier proteins are
also involved in other processes, such as transacylation
of bacterial oligosaccharides [1,2] and proteins [3,4],
K-aminoadipate reduction in yeast [5], and formation of
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L-alanyl-dopamine in Drosophila [6]. A characteristic fea-
ture of carrier proteins is the covalently bound 4P-phos-
phopantetheine (P-pant) prosthetic group. The P-pant
group plays a dual role in these multienzyme systems ^
acting as a nucleophile to activate acyl groups by a thio-
ester linkage to the terminal thiol and providing a £exible
arm (20 Aî ) to channel the growing intermediates between
the neighboring active sites [7,8]. In order to be functional,
all carrier proteins must be converted from the inactive
apo-forms to the functional holo-forms by the covalent
attachment of the P-pant group to a conserved serine res-
idue of the carrier proteins. This posttranslational modi¢-
cation is catalyzed by a superfamily of enzymes known as
phosphopantetheinyl transferases (PPTases) that derive
the P-pant group from coenzyme A (CoA) [9,10].
In organisms containing multiple P-pant-requiring path-
ways, each pathway has been suggested to have its own
posttranslational modifying PPTase activity [9,10]. This
hypothesis has been proved to be true in several organ-
isms. For example, three di¡erent PPTase activities are
known in the yeast Saccharomyces cerevisiae, encoded by
the PPT2, FAS2 (subunit K of cytoplasmic FAS where the
PPTase is integrated as a C-terminal domain), and LYS5
genes. The three PPTases speci¢cally modify di¡erent apo-
proteins ^ PPT2 acts on the type II ACP of mitochondrial
FAS, the PPTase domain of FAS2 acts intermolecularly
on the type I ACP domain located at the N-terminus of
the FAS subunit K itself, and Lys5 acts on the type I PCP
domain of the K-aminoadipate reductase Lys2 [5,11,12].
PPT2, FAS2, and Lys5 mutants show distinct phenotypes,
a¡ecting either respiration [11], fatty acid synthesis [13,14],
or lysine biosynthesis [15], respectively. Similarly, there are
three PPTases in Escherichia coli ^ ACPS for the speci¢c
modi¢cation of the type II ACP of the FAS complex,
EntD for the activation of the ArCP and type I PCP
domains of the NRPS complex involved in enterobactin
biosynthesis, and YhhU (also called o195) whose protein
substrate remains unknown [9,16]. (Very recently, it has
been reported that YhhU is able to modify apo-ACP in
vivo and to complement an acpS mutation, suggesting that
E. coli has evolved two enzymes capable of modifying
apo-ACP due to its essential role in cell survival [17].)
Furthermore, in vivo genetic studies have established
that several PPTases, such as Sfp in Bacillus subtilis (for
surfactin), Gsp in Bacillus brevis (for gramicidin), and
EntD in E. coli (for enterobactin), are required for non-
ribosomal peptide biosynthesis in these organisms, but are
not essential for their survival [18,19]. The latter results
suggest additional unidenti¢ed PPTases in the Bacillus or-
ganisms speci¢c for the ACPs of their respective FAS,
which, like E. coli ACPS, will be essential for cell viability.
All these examples support the view of co-evolution of
PPTases with their respective P-pant-requiring pathways.
Genes encoding the production of secondary metabo-
lites, such as nonribosomal peptides and polyketides, are
often clustered in one region of the bacterial chromosome.
Then, if every PKS or NRPS has its own dedicated
PPTase, one should expect to ¢nd a PPTase gene within
each cluster. This has indeed been the case for several gene
clusters encoding nonribosomal peptide biosynthesis, such
as those for enterobactin in E. coli [18], surfactin in B.
subtilis [20], and gramicidin in B. brevis [21], and polyke-
tide biosynthesis, such as those for nystatin in Streptomy-
ces noursei [22] and possibly landomycin in Streptomyces
cyanogenus [23]. One could then envisage the use of known
PPTase genes as additional probes for the cloning of novel
polyketide and nonribosomal peptide biosynthetic gene
clusters. However, exceptions to the clustering of PPTase
and NRPS genes are already known, such as the myco-
bactin biosynthetic gene cluster from Mycobacterium tu-
berculosis, which lacks the corresponding PPTase gene
[24]. In fact, PPTase genes have not been found to be
clustered with PKS genes in most of the polyketide bio-
synthetic gene clusters known to date.
Until very recently, research in polyketide and nonribo-
somal peptide biosynthesis was handicapped by the fre-
quent inability to produce fully active, holo-forms of
PKSs or NRPSs in heterologous hosts, probably because
the host PPTases either fail to recognize or act ine⁄ciently
on these carrier protein substrates. For that reason the
identi¢cation of the PPTase family and utilization of var-
ious PPTases, either in vivo or in vitro, to facilitate the
production of active PKSs and NRPSs have remarkably
accelerated the progress in this ¢eld [25^27]. We have been
studying the biosynthesis of bleomycin (BLM) in Strepto-
myces verticillus ATCC15003 as a model system to inves-
tigate intermodular communication between NRPS and
PKS modules [28^32]. BLM is an antitumor drug belong-
ing to a group of natural products of hybrid peptide^poly-
ketide origin, synthesized by a hybrid NRPS^PKS, the
Blm NRPS/PKS/NRPS megasynthetase [30]. This
prompted us to search for a PPTase from S. verticillus
in order to use it either in vitro or in vivo for the produc-
tion of properly modi¢ed, fully active Blm NRPS and
PKS proteins for our studies. We were particularly inter-
ested in ¢nding out (1) if the PPTase gene is clustered with
their respective NRPS or PKS genes, as we know that
S. verticillus contains at least three additional NRPS
gene clusters and one additional PKS gene cluster [28],
and (2) if a PPTase from a hybrid peptide^polyketide me-
tabolite-producing organism exhibits relaxed substrate
speci¢city towards both ACPs and PCPs. Here, we report
a general approach for identifying and cloning PPTase
genes from Streptomyces species, its application to the
cloning of an S. verticillus PPTase gene (svp), and the bio-
chemical characterization of Svp as a PPTase. The svp
gene seems not to be clustered to any of the NRPS or
PKS loci cloned previously from S. verticillus. The Svp
PPTase can e⁄ciently 4P-phosphopantetheinylate both
type I and type II ACPs and PCPs from either S. verti-
cillus or other Streptomyces species. Hence Svp should be
of great utility in engineered biosynthesis of polyketide,
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nonribosomal peptide, and, in particular, hybrid peptide^
polyketide natural products, many of which are clinically
important drugs such as BLM, rapamycin, and epothilone.
2. Results
2.1. Cloning of the svp gene from S. verticillus ATCC15003
by polymerase chain reaction (PCR)
The similarities among PPTases from di¡erent organ-
isms are reduced to two short motifs : (V/I)G(V/I)D (motif
P2) and (F/W)(S/C/T)XKE(A/S)hhK (h refers to a hydro-
phobic amino acid) (motif P3), separated by 40^45 resi-
dues [9,10]. PPTases have been previously classi¢ed ac-
cording to their carrier protein speci¢city into two
groups: PPTases for ACPs involved in fatty acid and poly-
ketide biosynthesis and PPTases for ArCPs and PCPs
involved in nonribosomal peptide and siderophore biosyn-
thesis [10]. Since the Blm NRPS/PKS/NRPS megasynthe-
tase contains at least 10 PCPs and only one ACP [30], we
decided to bias our search towards a PCP-speci¢c PPTase
from S. verticillus. Several PCP-speci¢c PPTase sequences
were used to screen the databases for homologues, limiting
only to those from actinomycetes. Seven proteins of un-
known function were found: LanZ6 from S. cyanogenus
(accession number AAD13565), NshC from Streptomyces
actuosus (accession number AAB17877) [33], NysF from
S. noursei (accession number AF263912) [22], Rv2794c
from Mycobacterium tuberculosis (accession number
A70885) [34], SC5A7.23 from Streptomyces coelicolor (ac-
cession number T35172), and two unnamed proteins from
Streptomyces sp. strain TH1 (accession number
BAA22407) [35] and Mycobacterium leprae (accession
number CAB36579). The alignment of these actinomycete
sequences not only con¢rmed the two conserved motifs,
P2 and P3, but also revealed an additional motif,
PXWPXGX2GS(M/L)THCXGY (motif P1), located
about 15 amino acids upstream of the P2 motif (Fig.
1A). We designed one forward primer for the P1 motif
(P1 primer) and two reverse primers around the P3 motif
(P3-1 and P3-2 primers) (Fig. 1B), using the recently de-
veloped CODEHOP strategy (COnsensus-DEgenerate Hy-
brid Oligonucleotide Primer) of PCR primer design [36].
While no product was detected when the P1/P3-1 pair of
primers was used, a distinct band with the expected size of
approximately 250 bp was readily ampli¢ed from S. verti-
cillus chromosomal DNA with the P1/P3-2 pair of prim-
ers. The PCR product was cloned, and eight randomly
selected clones were sequenced. All eight clones yielded
Fig. 1. (A) The three conserved motifs of PPTases from actinomycetes. The accession numbers are given in parentheses: Unnamed-1 (CAB36579),
Rv2794c (A70885), Svp (AF210331), SC5A7.23 (T35172), NysF, (AF263912), Unnamed-2 (BAA22407), LanZ6 (AAD13565), and NshC (AAB17877).
The numbers at two ends indicate the position of amino acids in the respective proteins, and the numbers between the motifs indicate the distance in
amino acids. (B) Primers designed for the P1 and P3 motifs according to the CODEHOP strategy [35]. H, C/A; K, G/T; N, A/C/T/G; R, A/G; W, T/
A; Y, C/T.
Fig. 2. Restriction map of the 4.7-kb BamHI fragment in pBS17 and ge-
netic organization of the sequenced svp locus. B, BamHI; N, NcoI ; K,
KpnI.
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an identical sequence (except di¡erences resulting from
primer utilization), which shows high homology to the
putative actinomycete PPTases (Fig. 1A). The PCR prod-
uct was then used as a probe to screen an S. verticillus
genomic library by colony hybridization. Of the 10 000
colonies screened, 25 positive clones were identi¢ed, and
subsequently con¢rmed by Southern analysis to contain
the same 4.7-kb BamHI fragment hybridizing to the probe
(Fig. 2).
2.2. Sequence analysis of the svp locus
The 4.7-kb BamHI fragment containing the PCR-ampli-
¢ed probe was subcloned (pBS17), and the nucleotide (nt)
sequence of a 1761-bp region was determined. Two incom-
plete open reading frames (ORFs), orf1 and orf4, and two
complete ORFs, svp and orf3, were identi¢ed within the
sequenced region (Fig. 2). The incomplete orf1 starts out
of the analyzed area and ends with a TGA codon at nt
248. The deduced product of orf1, the 81-amino acid
C-terminus, showed similarities to Rv2795c from M. tuber-
culosis (accession number CAA15590) and SC5A7.22 from
S. coelicolor (accession number CAA19951), both of un-
known function. The second ORF, svp, contains the PCR-
ampli¢ed probe used for the cloning of this locus. It starts
with a GTG codon at nt 245, which is translationally
coupled to the TGA stop codon of orf1, and ends with
a TAA codon at nt 983. The starting codon of svp is
preceded by a potential ribosomal binding site (RBS),
GGGAG. The overall (76.6%) and third codon position
(93.9%) G+C contents and the codon usage of svp are
similar to those found in other Streptomyces genes, with
the exception of the stop codon (TAA), which is uncom-
mon in this group of organisms [37,38]. The svp gene en-
codes a 246-amino acid protein with a predicted molecular
weight (MW) of 25 619 and an isoelectric point (pI) of
4.76. The deduced Svp protein contains all three conserved
PPTase motifs (Fig. 1A) and shows signi¢cant similarities
to the putative PPTases and their homologues of actino-
mycete origin, including LanZ6 (49% identity and 54%
similarity), NshC (50% identity and 54% similarity),
NysF (57% identity and 61% similarity), Rv2794c (49%
identity and 58% similarity), SC5A7.23 (60% identity
and 66% similarity), and the two unnamed proteins from
Streptomyces sp. TH1 (56% identity and 62% similarity)
and M. leprae (49% identity and 59% similarity). Interest-
ingly, the homology between Svp and PPTases from other
bacteria is signi¢cantly low, albeit apparent, such as the
con¢rmed PPTases EntD (17% identity and 24% similar-
ity) [18] and ACPS (18% identity and 30% similarity) from
E. coli [39], Gsp from B. brevis (19% identity and 25%
similarity) [25], and Sfp from B. subtilis (22% identity
and 34% similarity) [20]. The third ORF is separated
from svp by a 153-bp noncoding region. orf3 starts with
an ATG codon at nt 1358, preceded by a potential RBS
(GAAGG), and ends with a TGA codon at nt 1121. The
deduced ORF3 product shows similarities to the N-termi-
nal region of SC5H1.35c, a protein of unknown function
from S. coelicolor (accession number CAB42960). The
fourth ORF is separated from orf3 by a 251-bp noncoding
region. orf4 starts with an ATG codon at nt 1610, pre-
ceded by a potential RBS (GGAGG), and ending out of
the sequenced region. The deduced product of the incom-
plete orf4, the 50-amino acid N-terminus, contains a po-
tential NAD/FAD binding motif, GXGX2GX3GX6G [40],
hence showing low similarities to diverse oxidoreductases.
2.3. Overexpression in E. coli and puri¢cation of the Svp
protein
In order to test if svp encodes a functional PPTase, we
overexpressed the svp gene in E. coli and puri¢ed the Svp
protein to assay its catalytic competence on apo-ACPs or
apo-PCPs. We ampli¢ed the svp gene, using PCR, from
pBS17 and cloned it into the pQE-70 expression vector,
yielding pBS18, in such a way that Svp will be produced as
a fusion protein with a His6-tagged C-terminus. Introduc-
tion of pBS18 into E. coli M15(pREP4) under the stan-
dard overexpression conditions recommended by the man-
ufacturer resulted in overproduction of Svp predominantly
in soluble form (s 90%), which was readily puri¢ed by
a⁄nity chromatography on Ni-NTA agarose (Fig. 3).
The puri¢ed Svp protein migrates as a single band with
an apparent MW of 31 000 (calculated MW for His6-
tagged Svp is 26 830) upon sodium dodecyl sulfate^poly-
acrylamide gel electrophoresis (SDS^PAGE) and eluted
with apparent MW of 31 600 upon gel ¢ltration chroma-
tography. The abnormal mobility of PPTases upon SDS^
PAGE has been observed previously, such as Sfp migrat-
ing with an apparent MW of 32 000 (calculated MW of
26 135) [20] and Gsp migrating with an apparent MW of
30 000 (calculated MW of 27 856) [25].
Fig. 3. Expression and puri¢cation of Svp from E. coli
M15(pREP4)(pBS18). Lane 1, MW markers; 2, before IPTG induction;
3, after IPTG induction; 4, puri¢ed Svp.
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2.4. Overexpression in E. coli and puri¢cation of apo-ACPs
and apo-PCPs
To test Svp as a PPTase requires either apo-ACPs or
apo-PCPs. We chose BlmI and SgcORF26 as examples of
type II PCPs, the PCP domains of BlmVII and the second
NRPS module (NRPS-8) of BlmX as examples of type I
PCPs, TcmM as an example of type II ACP, and the
BlmVIII PKS as an example of a type I ACP (Fig. 4).
BlmI, BlmVII, BlmVIII, and BlmX are components of
the Blm NRPS/PKS/NRPS megasynthetase from S. verti-
cillus [28^31]. TcmM is the type II ACP of the well char-
acterized Tcm PKS complex catalyzing the biosynthesis of
tetracenomycin in Streptomyces glaucescens [41].
SgcORF26 is a type II PCP from the recently character-
ized gene cluster encoding the biosynthesis of the enediyne
antitumor antibiotic C-1027 in Streptomyces globisporus
[42]. We chose TcmM and SgcORF26 as substrates to
test the speci¢city of the Svp PPTase for carrier proteins
from other Streptomyces species.
We have previously reported the overproduction and
puri¢cation of BlmI [29]. To overproduce BlmVII-PCP
in E. coli, we determined the domain boundaries according
to Marahiel and co-workers [43,44], ampli¢ed the blmVII-
PCP fragment, using PCR, from pBS6 and cloned it into
pQE-60 to yield pBS19, in which BlmVII-PCP would be
produced as a fusion protein with a His6 tag at its
C-terminus. However, introduction of pBS19 into E. coli
M15(pREP4) under the standard overexpression condi-
tions recommended by the manufacturer yielded very
poor BlmVII-PCP production, as judged by SDS^PAGE
(data not shown). We then moved the blmVII-PCP frag-
ment from pBS19 into pET-29a to yield the second over-
expression construct, pBS20, in which BlmVII-PCP was
produced as a fusion protein with an S tag at the N-ter-
minus and a His6 tag at the C-terminus (Fig. 4). Introduc-
tion of pBS20 into E. coli BL21(DE-3) under the standard
overexpression conditions recommended by the manufac-
turer resulted in good production of BlmVII-PCP with
about 40% of the resultant protein in soluble form, which
was puri¢ed by a⁄nity chromatography on Ni-NTA aga-
rose. BlmVII-PCP is signi¢cantly longer (219 amino acids)
than a typical PCP domain (V90 amino acids) because we
used the native C-terminus of BlmVII (Fig. 4). The latter
has an additional 130-amino acid segment beyond the
PCP domain, which shows no apparent sequence homol-
ogy to any known proteins. The puri¢ed BlmVII-PCP mi-
grates as a single band with an apparent MW of 36 000
(Fig. 5A), signi¢cantly larger than the calculated MW of
BlmVII-PCP with both S and His tags of 26 758. Similar
abnormal mobility of both ACP and PCP upon SDS^
PAGE has been observed previously [2,44].
To overproduce BlmVIII in E. coli, the blmVIII gene
was ampli¢ed, using PCR, from pBS6 and cloned into
pQE-60 to yield pBS21, in which BlmVIII was produced
as a fusion protein with the His6 tag at the C-terminus
(Fig. 4). While introduction of pBS21 into E. coli
M15(pREP4) under the standard overexpression condi-
tions recommended by the manufacturer yielded nearly
completely insoluble protein, lowering the incubation tem-
perature to 30‡C and IPTG concentration to 200 WM im-
proved the solubility of the resultant BlmVIII protein
Fig. 4. ACPs (red) and PCPs (blue) used in this study. These carrier proteins are overproduced in E. coli as fusion proteins with various tags as indi-
cated. BlmI, SgcORF26, TcmM are monofunctional type II proteins. BlmVIII is a ¢ve-domain type I PKS, and BlmVII and BlmX are three-domain
and six-domain type I NRPSs, respectively. The numbers shown above the rectangles indicate amino acid residues. A, adenylation; AT, acyltransferase;
C, condensation; KR, ketoreductase; KS, ketoacyl synthase; MT, methyltransferase.
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without signi¢cant loss of the overall yield. BlmVIII was
subsequently puri¢ed by a⁄nity chromatography on Ni-
NTA agarose, and the puri¢ed BlmVIII protein migrates
as a single band upon SDS^PAGE with an apparent MW
of 195 000 (Fig. 5A), consistent with its calculated MW
plus the His tag of 193 378.
Various attempts to overproduce soluble BlmX-PCP8 in
E. coli, either as a PCP domain alone or in combination
with other domains with or without the His6 tag, were
unsuccessful. We ¢nally succeeded in overproducing
BlmX-(A-PCP)8 as a fusion protein with the maltose bind-
ing protein (MBP) (Fig. 4). Boundaries for the A and PCP
domains were similarly determined according to Marahiel
and co-workers [43,44]. Thus, we ampli¢ed the blmX-(A-
PCP)8 fragment, using PCR, from pBS6 and cloned it
into pMAL-c2x to yield pBS22, in which the MBP will
be fused to the N-terminus of BlmX-(A-PCP)8. Introduc-
tion of pBS22 into E. coli TB1 resulted in good production
of BlmX-(A-PCP)8 with approximately 40% of the resul-
tant protein in soluble form, which was subsequently pu-
ri¢ed by a⁄nity chromatography on amylose resin. The
puri¢ed BlmX-(A-PCP)8 protein migrates as one major
band upon SDS^PAGE with an apparent MW of
105 000 (Fig. 5A), consistent with its calculated MW
plus the MBP of 111 211.
To overproduce SgcORF26 in E. coli, the sgc-orf26 gene
was ampli¢ed, using PCR, from pBS1006 [42] and cloned
into pET-29a to yield pBS23, in which SgcORF26 was
produced as a fusion protein with a native N-terminus
and a His6-tagged C-terminus. No production of
SgcORF26 could be detected, however, as judged by
SDS^PAGE, upon introduction of pBS23 into E. coli
BL21(DE3) under various conditions examined. We sub-
sequently moved the sgc-orf26 gene from pBS23 into pET-
28a to a¡ord pBS24, in which SgcORF26 was produced as
a fusion protein with His6 tags at both the N- and
C-termini (Fig. 4). Introduction of pBS24 into E. coli
BL21(DE3), followed by fermentation at 30‡C and induc-
tion with 100 WM IPTG, resulted in the overproduction of
SgcORF26 with about 15% of the resultant protein in
soluble form, which was subsequently puri¢ed by a⁄nity
chromatography on Ni-NTA agarose. The puri¢ed
SgcORF26 protein migrates as a single band upon SDS^
PAGE with an apparent MW of 13 000 (Fig. 5A), consis-
tent with its calculated MW plus the two His tags of
13 283.
Expression of tcmM in E. coli has been previously re-
ported [41]. To facilitate puri¢cation, the tcmM gene was
moved from pET22b-tcmhis6 [45] into pET-28a to yield
pBS25, in which TcmM was overproduced as a fusion
protein with His6 tags at both the N- and C-termini
(Fig. 4). Introduction of pBS25 into E. coli BL21(DE3)
under the standard expression conditions recommended
by the manufacturer resulted in overproduction of soluble
TcmM, which was readily puri¢ed by a⁄nity chromatog-
raphy on Ni-NTA agarose. The puri¢ed TcmM protein
migrates as a single band upon SDS^PAGE with an ap-
parent MW of 13 500 (Fig. 5A), consistent with its calcu-
lated MW plus the two His tags of 12 312.
2.5. In vitro 4P-phosphopantetheinylation of apo-ACPs and
apo-PCPs with [3H-pantetheine]-CoA by Svp
To establish Svp as a PPTase, we tested whether it can
Fig. 5. In vitro 4P-phosphopantetheinylation of apo-PCPs and apo-ACPs by Svp in comparison to Sfp. Carrier protein and PPTase concentrations used
in each assay (100 Wl) were: 11.6 WM BlmI, 5.8 WM BlmVII-PCP, 0.8 WM BlmVIII, 1.5 WM BlmX-(A-PCP)8, 11.6 WM SgcORF26, or 11.6 WM TcmM,
and 1.5 WM Svp or Sfp. (A) SDS^PAGE analysis on a 7.5% (left panel) and 15% gels (right panel). (B) Autoradiogram.
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catalyze 4P-phosphopantetheinylation of an apo-ACP or
apo-PCP into a holo-ACP or holo-PCP by transferring
the P-pant moiety from CoA to the conserved serine res-
idue of the carrier protein in vitro. Sfp, the PPTase from
the surfactin biosynthetic gene cluster of B. subtilis that is
known for its broad substrate speci¢city for both ACPs
and PCPs [46], was chosen as a positive control. The Sfp
PPTase was overproduced in E. coli MV1190 (pUC8-Sfp)
and puri¢ed to near homogeneity as described previously
[20]. Upon incubation of the puri¢ed apo-ACPs and apo-
PCPs with [3H-pantetheine]-CoA in the presence of either
the Svp or Sfp PPTase, we examined the covalent incor-
poration of the [3H]P-pant moiety from CoA into holo-
ACPs or holo-PCPs using autoradiographic analysis. The
results are summarized in Fig. 5. As compared to Sfp, Svp
is competent for the 4P-phosphopantetheinylation of both
apo-ACPs and apo-PCPs by speci¢cally transferring the
P-pant group from CoA onto holo-carrier proteins, and
no P-pant incorporation was observed in the absence of
either the carrier proteins or the Svp or Sfp PPTase. Sur-
prisingly, when [3H]acetyl CoA was used as a substrate to
test the speci¢city of Svp, the autoradiogram signals were
very weak for either type I or type II ACPs/PCPs even
after 2 weeks exposure; under identical conditions the
positive control of BlmI with [3H-pantetheine]-CoA as a
substrate gave very strong signal (Fig. 6). Both ACPS of
E. coli [45] and Sfp of B. subtilis [46] have previously been
shown by mass spectrometry to be able to utilize a range
of CoA analogs with altered P-pant moieties as substrates,
including acetyl CoA. The relaxed substrate speci¢city of
Sfp was successfully exploited to load aminoacyl-phospho-
pantetheine to PCP for NRPS characterization [27]. How-
ever, under the same conditions Sfp also gave negligible
signal on autoradiogram when [3H]acetyl-CoA was used
as a substrate (Fig. 6). These data suggest that the transfer
of altered P-pant moieties, observed by mass spectrometry
Table 1
Catalytic e⁄ciencies of Svp-catalyzed phosphopantetheinylation of apo-
BlmI PCP and apo-TcmM ACP in comparison with those of Sfp
PPTase Substrate Km
(WM)
kcat
(min31)
kcat/Km
(WM31 min31)
Svp BlmI 3.9 þ 1.4 11 þ 1.3 2.8 þ 1.1
TcmM 3.1 þ 1.1 86 þ 9.3 28 þ 10
Sfp BlmI 3.7 þ 1.4 7.2 þ 0.85 1.9 þ 1.0
TcmM 11 þ 2.7 0.89 þ 0.11 0.081 þ 0.022
Fig. 7. Initial velocities of 4P-phosphopantetheinylation of apo-BlmI
PCP (8, blue) and apo-TcmM ACP (b, red) catalyzed by Svp (A) in
comparison to Sfp (B) as a function of concentration of apo-BlmI PCP
or apo-TcmM ACP.
Fig. 6. In vitro 4P-phosphopantetheinylation of apo-PCPs and apo-
ACPs using [3H-pantetheine]-CoA or [3H]acetyl-CoA as a substrate by
Svp in comparison of Sfp. Carrier protein, phosphopantetheinylation
transferase, CoA or acetyl-CoA concentrations used in each assay (100
Wl) were: 11.6 WM BlmI, 5.8 WM BlmVII-PCP, 11.6 WM SgcORF26,
11.6 WM TcmM, or 5.8 WM Val-PCP, 1.5 WM Svp or Sfp, and 0.23 WM
[3H-pantetheine]-CoA (0.43 WCi) or [3H]acetyl-CoA (1 WCi). Val-PCP is
the PCP domain of the SvPS-2 NRPS module from the second gene
cluster cloned from S. verticillus ATCC15003 that is also characterized
by both NRPS and PKS genes (accession number AF340166).
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in the early studies [27,45,46], probably represents a minor
activity of the PPTases.
2.6. Kinetics of apo-TcmM ACP and apo-BlmI PCP as
substrates for Svp and Sfp
Initial rate assays were used to determine the kinetic
parameters for P-pant transfer from CoA to both apo-
TcmM and apo-BlmI, using both Svp and Sfp as catalysts.
Saturation kinetics for the carrier proteins were observed
(Fig. 7). As shown in Table 1, the Km values for BlmI with
either Svp or Sfp are identical (V4 WM) within experimen-
tal error, while the kcat values are very similar. In contrast,
the two PPTases show signi¢cantly di¡erent Km values
and very di¡erent kcat values for TcmM. These two kinetic
parameters combine to provide the catalytic e⁄ciency,
kcat/Km. With BlmI as substrate, kcat/Km for both Svp
and Sfp is identical within experimental error. With
TcmM as substrate, kcat/Km is very di¡erent for the two
enzymes, with Svp being a 346-fold better catalyst.
2.7. Cloning of PPTase gene fragments from other peptide
or polyketide natural product-producing Streptomyces
species
To test the general utility of the PCR approach for
identifying and cloning PPTase genes, PCR reactions
were performed using the P-1/P3-2 pair of primers on
chromosomal DNAs prepared from ¢ve di¡erent Strepto-
myces species. S. coelicolor A3(2) was chosen as a positive
control since it is known to contain a Sfp-like sequence
(SC5A7.23, accession number CAA19952). Streptomyces
atroolivaceus and Streptomyces albus JA3495 produce lei-
namycin [47] and oxazolomycin [48], respectively, both of
which are hybrid peptide^polyketide metabolites. Strepto-
myces griseus DSM40695 produces the macrotetrolides
that are polyketides [49]. Distinctive products with the
expected size of approximately 250 bp were readily ampli-
¢ed from the chromosomal DNAs of all ¢ve organisms.
These fragments were cloned and sequenced. The deduced
amino acid sequences are characterized by the conserved
P2 motif and show high homology among each other as
well as to putative and known PPTases such as Svp (Fig.
8). Therefore, it is evident that these fragments encode
parts of PPTases, and this approach provides a novel ac-
cess to PPTase genes for peptide and polyketide biosyn-
thesis.
3. Discussion
The antitumor drug BLM is a natural hybrid peptide^
polyketide metabolite, the biosynthesis of which provides
an excellent opportunity to investigate intermodular com-
munication between NRPS and PKS modules. At the on-
set of this project, it seemed that bacterial NRPS gene
clusters generally included, or were located in the proxim-
ity of, a gene encoding the pathway-speci¢c PPTase
[18,20,21]. However, sequence analysis of the blm cluster
had failed to reveal an associated PPTase gene [30]. Since
neither NRPS nor PKS will be functional unless its carrier
protein is fully modi¢ed by the attachment of the P-pant
group to the conserved serine residue, we decided to
search for a PPTase from S. verticillus that presumably
would be responsible for the modi¢cation of both ACP
and PCPs of the Blm NRPS/PKS/NRPS megasynthetase.
Although sequence conservation among PPTases from dif-
ferent organisms, limited to two poorly de¢ned motifs, P2
and P3 (Fig. 1A), has been previously recognized [9,10],
initial attempts to amplify a PPTase from S. verticillus by
PCR, using degenerate primers designed according to the
P2 and P3 motifs, were unsuccessful. We then used a se-
quence comparison strategy, taking into account the fol-
lowing two considerations. First, we biased our search
Fig. 8. Alignment of the deduced amino acid sequences of the cloned PPTase fragments from di¡erent Streptomyces species. These fragments were
cloned by PCR using the P1/P3-2 pair of primers designed according to the conserved P1 and P3 motifs of PPTases from actinomycetes. The conserved
P2 motif is present in all cloned PPTase fragments.
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towards a PCP-speci¢c PPTase since the blm locus encodes
at least 10 NRPS modules but only one PKS module [30].
Second, we used the con¢rmed PCP-speci¢c PPTases to
search the database for homologues only from the closely
related Streptomyces and Mycobacterium genera. In this
way, we identi¢ed a new motif, P1, in addition to the P2
and P3 motifs (Fig. 1A). Realizing that these motifs con-
sist of only a few amino acids, we took advantage of the
recently developed CODEHOP strategy of PCR primer
design [36]. PCR ampli¢cation using CODEHOP-designed
primers yielded a speci¢c DNA fragment of the expected
size from S. verticillus genomic DNA, leading to the clon-
ing of the svp gene. The svp gene is not clustered with any
of the NRPS or PKS gene clusters known in S. verticillus.
The general utility of this PCR approach for identifying
and cloning PPTase genes was demonstrated in the four
additional Streptomyces species tested. Given the current
interests in peptide and polyketide biosynthesis and the
inability to identify a PPTase associated with the speci¢c
NRPS or PKS clusters, our approach should be directly
applicable to the cloning of a PPTase gene from organisms
known to produce peptide, polyketide or hybrid peptide^
polyketide metabolites, in particular from the high G+C
content actinomycetes.
PPTases characterized to date exhibit high speci¢city
towards the carrier protein substrates, leading to the pro-
posal that each P-pant-requiring pathway has its own
posttranslational modifying PPTase activity [9]. Sfp, the
only PPTase known prior to our work to accept ACPs,
ArCP, and PCPs from various organisms, has been called
a ‘promiscuous’ PPTase whose relaxed carrier protein spe-
ci¢city has been viewed as an exception to the aforemen-
tioned hypothesis. We overexpressed and puri¢ed Svp and
demonstrated it to be a PPTase that is also able to accept
a wide variety of apo-carrier proteins as substrates, includ-
ing both type I and type II ACPs and PCPs from either
S. verticillus or other Streptomyces species. The kinetic
analyses presented here show that the catalytic e⁄ciencies
of Svp and Sfp are very similar for apo-BlmI as a sub-
strate, but, strikingly, Svp is a 346-fold better catalyst than
Sfp with apo-TcmM as a substrate. These results not only
con¢rmed that svp encodes a PPTase, but also prompted
us (1) to reconsider the early assumption that each P-pant-
requiring pathway has its own PPTase activity and (2) to
re-examine the previous classi¢cation of PPTases into ei-
ther NRPS-type or FAS/PKS-type according to their car-
rier protein speci¢city [10].
Very recently, the X-ray crystal structure of Sfp has
been solved [50]. Instead of classifying PPTases according
to their apparent carrier protein speci¢city, the PPTase
superfamily was re-classi¢ed on a structural basis into
two subfamilies: Sfp-type PPTases that are monomers of
about 230 amino acids and ACPS-type PPTases that are
homodimers with the subunit of about half the size of the
Sfp-type enzymes [50]. Interestingly, the structure of Sfp
exhibits an intramolecular two-fold pseudosymmetry, sug-
gesting a similar fold and dimerization mode to the ho-
modimeric ACPS-type PPTases [50]. However, the even
more recent elucidation of the structure of AcpS from
B. subtilis and the characterization of AcpS from Strepto-
coccus pneumoniae show that, at least in the group of low
G+C Gram-positive bacteria, ACPS enzymes exist as ho-
motrimers [51,52]. Each trimer contains three active sites,
one half of which comes from one molecule of AcpS and
the other half from a second AcpS molecule in the trimer.
The active site in AcpS is only formed when two AcpS
molecules dimerize, but the enzyme remains inactive until
trimer formation [51]. These features have led us to the
following speculation on the structural and functional evo-
lution of PPTases. The small ACPS-type oligomeric en-
zyme might be considered the ‘ancestral’ form of PPTase,
now conserved in most bacterial fatty acid biosynthesis
pathways. In one evolutionary route, after a gene fusion
event, this discrete ACPS-like protein became a domain in
fungal multifunctional FAS. It is notable that even in this
new context, the PPTase seems to conserve its oligomeric
(dimeric) nature [9,12,14]. Therefore, the ACPS-type
PPTases, both discrete proteins and FAS domains, are
more dedicated enzymes, generally involved in fatty acid
biosynthesis, and, hence, are essential for survival. Follow-
ing a di¡erent evolutionary path, after a DNA duplication
event and further accumulation of mutations, the oligo-
meric ACPS-like subunit became a monomeric PPTase of
the Sfp type, twice the size of its ACPS-type ancestor. The
Sfp-type enzymes are involved in functions not essential
under normal conditions, such as biosynthesis of second-
ary metabolites. Therefore they are ‘free’ to develop a
broader substrate speci¢city such as Sfp and Svp, poten-
tially serving several pathways. Our ¢ndings that Svp is a
monomeric, 246-amino acid PPTase with a broad sub-
strate speci¢city and is probably involved in BLM biosyn-
thesis support these speculations.
We further propose that Svp may be the only PPTase
responsible for secondary metabolite biosynthesis in
S. verticillus. This is consistent with the fact that (1) PCR
using degenerate primers designed according to known
PPTases yielded only one single product, as evidenced by
the fact that eight randomly selected clones yielded an
identical sequence; (2) DNA probing of the genomic li-
brary using the PCR-ampli¢ed probe resulted in only one
single svp locus, in spite of exercising great care not to
miss any possible weak hybridizing signal from multiple
PPTase loci ; and (3) the broad substrate speci¢city of Svp
towards both ACPs and PCPs so that no additional
PPTase is needed for the other NRPS and PKS clusters.
Nonribosomal peptide, polyketide, and hybrid peptide^
polyketide natural products encompass a wide array of
clinically important drugs, and genetic engineering of
NRPS and PKS has proved to be extremely powerful in
expanding the repertoire of natural product libraries,
hence potentially leading to the discovery of new drugs
[32,53]. Since neither NRPS nor PKS will be functional
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unless its carrier proteins are fully modi¢ed with the
P-pant group, Sfp has been by far the most important
PPTase currently used to produce active NRPS and PKS
for these studies. The Svp PPTase reported here could be
easily overproduced in and puri¢ed from E. coli and
showed as broad substrate speci¢city as Sfp if not broader,
exhibiting an excellent catalytic e⁄ciency toward both
ACPs and PCPs. Given the fact that most of the current
e¡orts on combinatorial NRPS and PKS biosynthesis are
carried out in Streptomyces or closely related actinomy-
cetes, Svp should be of great utility, either in vitro or in
vivo by co-expression with the NRPS or PKS genes, to
produce functional enzymes. Moreover, since Svp can
phosphopantetheinylate e⁄ciently both ACPs and PCPs,
it should be particularly useful in engineering biosynthesis
of hybrid peptide^polyketide natural products [32,53]. The
latter family includes many important drugs, such as
BLM, rapamycin, pristinamycin, and epothilone.
4. Signi¢cance
PPTases have been classi¢ed according to their carrier
protein speci¢city, and, in organisms containing multiple
P-pant-requiring pathways, each pathway has been sug-
gested to have its own PPTase activity. We developed a
PCR method for cloning PPTase genes from actinomy-
cetes and cloned a PPTase gene, svp, from S. verticillus,
the producer of the antitumor drug bleomycin. The svp
gene was mapped to an independent locus not clustered
with any of the known NRPS or PKS clusters. Svp is a
PPTase capable of modifying both type I and type II
ACPs and PCPs from either S. verticillus or other Strep-
tomyces species. As compared to Sfp, the only ‘promiscu-
ous’ PPTase known previously, Svp displays a similar cat-
alytic e⁄ciency (kcat/Km) for the BlmI PCP but a 346-fold
increase in catalytic e⁄ciency for the TcmM ACP. Our
results favor the structural based re-classi¢cation of
PPTases into two subfamilies : ACPS-type and Sfp-type.
ACPS-type PPTases are generally involved in fatty acid
biosynthesis and, hence, are essential for survival. Sfp-
type PPTases, to which Svp belongs, are generally respon-
sible for secondary metabolite biosynthesis, hence non-es-
sential, and may evolve new or broader speci¢cities to-
wards their carrier protein substrates. Since neither
NRPS nor PKS will be functional unless its carrier pro-
teins are fully modi¢ed with the P-pant group, the devel-
opment of a PCR method for cloning PPTase genes, and
the availability of Svp, in addition to Sfp, should facilitate
future endeavors in engineered biosynthesis of peptide,
polyketide, and, in particular, hybrid peptide^polyketide
natural products.
5. Materials and methods
5.1. General procedures
E. coli DH5K [54], E. coli BL21(DE-3) (Novagen, Madison,
WI, USA), E. coli M15(pREP4) (Qiagen, Santa Clarita, CA,
USA), E. coli TB1 (New England Biolabs, Beverly, MA, USA),
S. albus JA 3453 [48], S. atroolivaceus [47], S. coelicolor A3(2)
[55], S. griseus DSM DSM40695 (Deutsche Sammlung von
Mikroorganismen und Zellkulturen, Braunschweig, Germany)
[49], S. verticillus ATCC15003 (American Type Culture Collec-
tion, Rockville, MD, USA) [30] were used in this work. E. coli
MV1190 (pUC8-Sfp) [25], pBS6 [30], pBS1006 [42], pET22b-
tcmhis6 [45], and pANT841 [56] were described previously, and
pET28a and pET-29a (Novagen), pGEM-T (Promega, Madison,
WI, USA), pMAL-c2x (New England Biolabs), and pQE60 and
pQE70 (Qiagen) were from commercial sources.
Plasmid preparation was carried out using commercial kits
(Qiagen). Streptomyces chromosomal DNA was isolated accord-
ing to literature protocols [54,55]. Restriction enzymes and other
molecular biology reagents were from commercial sources, and
digestion and ligation followed standard methods [54]. For
Southern analysis, digoxigenin labeling of DNA probes, hybrid-
ization, and detection were performed according to the protocols
provided by the manufacturer (Boehringer Mannheim Biochem-
icals, Indianapolis, IN, USA).
Automated DNA sequencing was carried out on an ABI Prism
377 DNA Sequencer (Perkin-Elmer/ABI, Foster City, CA, USA).
This service was provided by Davis Sequencing Inc. (Davis, CA,
USA). Data were analyzed by the ABI Prism Sequencing 2.1.1
software and the Genetics Computer Group (GCG) program
(Madison, WI, USA).
5.2. PCR cloning of PPTase genes and isolation and sequencing of
the svp locus
The primers were designed according to the conserved motifs
found in putative PCP-type PPTases from actinomycetes (Fig. 1)
by the CODEHOP strategy [36]. The reaction mixture contained
50 mM KCl, 10 mM Tris^HCl, pH 9.0, 0.1% Triton X-100,
1.5 mM MgCl2, 5% dimethyl sulfoxide, 0.25 mM of each of the
four dNTPs, 100 pmol of each primer, 2.5 U Taq DNA polymer-
ase (Promega), and 50 ng of Streptomyces chromosomal DNA, in
a ¢nal volume of 50 Wl. A touchdown PCR program was used,
which consists of (1) denaturation at 95‡C for 5 min, (2) 10 cycles
of 40 s at 95‡C, 1 min at 60^51‡C (decreasing 1‡C every cycle)
and 20 s at 72‡C, (3) 30 cycles of 40 s at 95‡C, 1 min at 50‡C and
20 s at 72‡C, and (4) 7 min at 72‡C. The 250-bp products, am-
pli¢ed with the P1/P3-2 primers were gel-puri¢ed, cloned into
pGEM-T, and sequenced. To clone the svp gene, the PCR prod-
uct was cloned into pGEM-T to yield pBS26 and used as a probe
to screen the S. verticillus genomic library [30]. Among the 10 000
colonies analyzed, 25 clones were true positive by Southern anal-
ysis and hybridized to the same 4.7-kb BamHI fragment. One of
the cosmid clones, pBS27, was chosen, from which the 4.7-kb
BamHI fragment was cloned into pANT841 to yield pBS17.
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The 1761-bp DNA sequence reported in this work was deter-
mined from pBS17.
5.3. Overexpression in E. coli and puri¢cation of Svp, BlmI,
BlmVII-PCP, BlmVIII, BlmX-(A-PCP)8, SgcORF26,
and TcmM
The svp gene was ampli¢ed by PCR from pBS17 using a for-
ward primer 5P-TATAATGCATGCTCGCCGCCCTCCCC-3P
(the SphI site is underlined) and a reverse primer 5P-TTAAGA-
TCTCGGGACGGCGGTCCGGTC-3P (the BglII site is under-
lined). The resultant PCR product was digested and cloned into
the SphI-BglII sites of pQE-70 to yield pBS18. The latter was
introduced into E. coli M15(pREP4) under standard expression
conditions, in which Svp will be produced with an Ile-to-Leu
mutation at the second amino acid, due to the introduction of
the SphI site, and an Arg-Ser-His6 tag at the C-terminus.
Overexpression and puri¢cation of BlmI was carried out as
described previously [29]. To overproduce BlmVII-PCP, the
C-terminal 657-bp fragment of blmVII was ampli¢ed by PCR
from pBS6 using a forward primer 5P-ATATCCATGGCG-
GCCTTGCCCGACCCGGCC-3P (the NcoI site is underlined)
and a reverse primer 5P-GGAAGATCTTTCGGGACGCGGG-
CACGGCTG-3P (the BglII site is underlined). The resultant
PCR product was digested and cloned into the NcoI-BglII sites
of pQE-60 to yield pBS19 for overexpression in E. coli
M15(pREP4). Due to poor production, blmVII-PCP was subse-
quently moved as an NcoI-HindIII fragment from pBS19 and
cloned into the same sites of pET-29a to a¡ord pBS20 for ex-
pression in E. coli BL21(DE3). In the latter construct, BlmVII-
PCP will be produced as a fusion protein with an S tag at the
N-terminus and a His6 tag at the C-terminus.
The blmVIII gene was ampli¢ed by PCR from cosmid pBS6
using a forward primer 5P-TGAATTCCATGGGCCATGCCG-
ACGCGGGCGAC-3P (the NcoI site is underlined) and a reverse
primer 5P-ATGGATCCCAGCACCACCTCTTCCTGGC-3P (the
BamHI site is underlined). The resultant PCR product was
digested and cloned into the NcoI-BglII sites of pQE60, and a
3.6-kb KpnI/BglII fragment from pBS6 was subsequently used to
replace the corresponding region of the PCR-ampli¢ed blmVIII
gene to eliminate any possible PCR error, yielding pBS21. Intro-
duction of pBS21 into E. coli BL21(DE3) under standard expres-
sion conditions resulted in production of BlmVIII as a fusion
proteins with a His6 tag at the C-terminus.
To overproduce BlmX-(A-PCP)8, the C-terminal 1881-bp frag-
ment of blmX was ampli¢ed by PCR from pBS6 using a forward
primer 5P-TAGAATTCCGCTCCGACCGCGAC-3P (the EcoRI
site is underlined) and a reverse primer 5P-TATTCTCGAGT-
CATTCGGCGGCACCTC-3P (the XhoI site is underlined). The
resultant PCR product was digested and cloned into the EcoRI-
SalI sites of pMAL-c2x to yield pBS22. Introduction of pBS22
into E. coli TB1 under standard expression conditions resulted in
production of BlmX-(A-PCP)8 as a fusion protein with the MBP
at the N-terminus.
From pBS1006, sgc-orf26 was ampli¢ed by PCR using a for-
ward primer 5P-GGGAATTCCATATGTCCACCGTTTCCGA-
CAC-3P (the NdeI site is underlined) and a reverse primer 5P-
GGCAAGCTTCTGCGTTCCGGAGCCCTC-3P (the HindIII
site is underlined). The resultant PCR product was digested and
cloned into the NdeI-HindIII sites of pET29a to give pBS23, in
which SgcORF26 would be produced as a fusion protein with a
native N-terminus and a His6 tag at the C-terminus. To construct
pBS24, sgc-orf26 was moved as an NdeI/HindIII fragment from
pBS23 and cloned into the same sites of pET28a. The latter
resulted in the production of SgcORF26 as a fusion protein
with His6 tags at both N- and C-termini. Both pBS23 and
pBS24 were introduced into E. coli BL21(DE3) under standard
expression conditions.
To construct pBS25, tcmM was moved as an NdeI-XhoI frag-
ment from pET22b-tcmhis6 and cloned into the same sites of
pET-28a. Introduction of pBS25 into E. coli BL21(DE3) under
standard expression conditions resulted in production of TcmM
as a fusion protein with His6 tags at both N- and C-termini.
Puri¢cation of His-tagged proteins by a⁄nity chromatography
on Ni-NTA resin was carried out as previously described [29].
Puri¢cation of the MBP fusion protein by a⁄nity chromatogra-
phy on amylose resin was carried out as recommended by the
manufacturer.
5.4. In vitro phosphopantetheinylation of apo-ACPs and apo-PCPs
For in vitro phosphopantetheinylation, the reaction mixtures
contained 0.8^11.6 WM apo-PCP or apo-ACP, 1.5 WM Svp or
Sfp, 0.225 WM [3H-pantetheine]-CoA (0.43 WCi, 40 Ci/mmol), 5
mM dithiothreitol (DTT), 10 mM MgCl2, 75 mM Tris^HCl, pH
8.0, in a ¢nal volume of 100 Wl. For assays using [3H-pante-
theine]-CoA and [3H]acetyl-CoA to compare the substrate specif-
icity between Svp and Sfp, 50 mM sodium phosphate bu¡er, pH
6.5 was used. The assays were initiated by addition of [3H-pan-
tetheine]-CoA, allowed to incubate at 37‡C for 1 h, and termi-
nated by addition of 900 Wl of cold 10% trichloroacetic acid
(TCA). All procedures are essentially the same as previously de-
scribed [27]. The samples were resolved by SDS^PAGE on a 15%
(for BlmI, SgcORF26, BlmVII-PCP, TcmM) or a 7.5% gel (for
BlmX-(A-PCP)8 and BlmVIII). The gels were soaked in Ampli¢er
(Amersham, Arlington Heights, IL, USA) for 20 min, dried be-
tween two sheets of cellulose membrane (KOH Development
Inc., Ann Arbor, MI, USA), and visualized by autoradiography
on X-ray ¢lms (Fuji Medical Systems, Stanford, CT, USA).
5.5. Kinetics of Svp and Sfp with BlmI and TcmM
The pH pro¢le of Svp was determined in 75 mM MES/sodium
acetate (for pH 4.5^6.5) and 75 mM Tris^HCl (for pH 7.0^9.5)
bu¡ers. Svp exhibits an optimal activity around pH 6.5^7.0. Ki-
netic studies were carried out at pH 8.0 to avoid substrate inhi-
bition and precipitation of the carrier proteins at high concen-
trations. Full time courses for P-pant transfer were used to
determine the time frame in which initial rate conditions
(6 10% conversion) were maintained. For time courses, the re-
actions contained 11.6 WM BlmI or TcmM, 15 nM Svp or Sfp,
11.6 WM [3H-pantetheine]-CoA (0.43 WCi, 373 mCi/mmol), 5 mM
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DTT, 10 mM MgCl2, 75 mM Tris^HCl, pH 8.0, in a ¢nal volume
of 800 Wl. All reactions were initiated by addition of [3H-pante-
theine]-CoA and allowed to incubate at 37‡C. An aliquot of
100 Wl was taken at 1, 2, 5, 10, 20, 30, 60 min and transferred
into a tube containing 50 Wg bovine serum albumin (BSA) on ice,
to which 900 Wl of cold 10% TCA was added immediately to
terminate the reaction. Precipitated proteins were isolated,
washed, and suspended in 100 Wl of 1 M Tris^HCl, pH 8.0. All
procedures are essentially the same as previously described [46].
The protein samples were then mixed with 7 ml of scintillation
£uid (ScintiSafe Gel, Fisher, Pittsburgh, PA, USA) and counted
on a Beckman LS-6800 scintillation counter to determine the
radioactivity.
The time courses described above showed that initial rate con-
ditions are obtained up to at least 5 min of reaction. The initial
rate reactions contained 1.16^17.4 WM apo-BlmI or apo-TcmM,
15 nM Svp or Sfp, 11.6 WM [3H-pantetheine]-CoA (0.43 WCi, 373
mCi/mmol), 5 mM DTT, 10 mM MgCl2, 75 mM Tris^HCl, pH
8.0, in a ¢nal volume of 100 Wl. The reactions were initiated by
addition of [3H-pantetheine]-CoA, incubated at 37‡C for 5 min,
and terminated by addition of 900 Wl of cold 10% TCA and 50 Wg
of BSA. Radioactivities associated with the precipitated proteins
were similarly determined by scintillation counting. Experiments
in which CoA was varied (0.34^112 WM) at ¢xed apo-BlmI or
apo-TcmM concentration (29 WM) yielded Km values of 1.6 þ 0.7
WM (Svp/BlmI), 0.62 þ 0.11 WM (Sfp/BlmI), and 1.5 þ 0.5 WM
(Sfp/TcmM). The reported value for the latter is 0.7 WM [46].
Thus, the CoA concentration used (11.6 WM) in the initial rate
experiments with apo-BlmI and apo-TcmM is saturating. The
initial rate data were ¢tted directly to the Michaelis^Menten
equation using the nonlinear regression available in Kaleidagraph
(ver. 3.09) (Synergy Software, Reading, PA, USA).
5.6. Accession number
The nucleotide sequence of the svp locus from S. verticillus
ATCC15003 has been deposited into GenBank under accession
number AF210311.
Acknowledgements
We thank Kyowa Hakko Kogyo Co., Ltd., Tokyo,
Japan, for providing S. atroolivaceus and Prof. Dr. W.F.
Fleck, Hans-Kno«ll-Institut fu«r Natursto¡-Forschung,
Jena, Germany, for providing S. albus JA 3453. This
work was supported in part by an Institutional Research
Grant from the American Cancer Society and the School
of Medicine, University of California, Davis ; the National
Institutes of Health Grant AI40475; and the Searle
Scholars Program/The Chicago Community Trust. C.S.
was supported in part by a postdoctoral fellowship
from the Spanish Ministry of Education and Culture.
D.E. was supported in part by a NIH Training Grant
GM07377.
References
[1] O. Geiger, H.P. Spaink, E.P. Kennedy, Isolation of the Rhizobium
leguminosarum NodF nodulation protein: NodF carries a 4P-phos-
phopantetheine prosthetic group, J. Bacteriol. 173 (1991) 2872^2878.
[2] G. Epple, K.M. van der Drift, J.E. Thomas-Oates, O. Geiger, Char-
acterization of a novel acyl carrier protein, RkpF, encoded by an
operon involved in capsular polysaccharide biosynthesis in Sinorhi-
zobium meliloti, J. Bacteriol. 180 (1998) 4950^4954.
[3] J.P. Issartel, V. Koronakis, C. Hughes, Activation of Escherichia coli
prohaemolysin to the mature toxin by acyl carrier protein-dependent
fatty acylation, Nature 351 (1991) 759^761.
[4] P. Stanley, V. Koronakis, C. Hughes, Acylation of Escherichia coli
hemolysin: a unique protein lipidation mechanism underlying toxin
function, Microbiol. Mol. Biol. Rev. 62 (1998) 309^333.
[5] D.E. Ehmann, A.M. Gehring, C.T. Walsh, Lysine biosynthesis in
Saccharomyces cerevisiae : mechanism of K-aminoadipate reductase
(Lys2) involves posttranslational phosphopantetheinylation by Lys5,
Biochemistry 38 (1999) 6171^6177.
[6] B.T. Hovemann, R-P. Ryseck, U. Walldorf, K.F. Sto«rtkuhl, I.D.
Dietzel, E. Dessen, The Drosophila ebony gene is closely related to
microbial peptide synthetases and shows speci¢c cuticle and nervous
system expression, Gene 221 (1998) 1^9.
[7] D.A. Hopwood, D.H. Sherman, Molecular genetics of polyketides
and its comparison to fatty acid biosynthesis, Annu. Rev. Genet.
24 (1990) 37^66.
[8] H. Kleinkauf, H. von Do«hren, A nonribosomal system of peptide
biosynthesis, Eur. J. Biochem. 236 (1996) 335^351.
[9] R.H. Lambalot, A.M. Gehring, R.S. Flugel, P. Zuber, M. LaCelle,
M.A. Marahiel, R. Reid, C. Khosla, C.T. Walsh, A new enzyme
superfamily ^ the phosphopantetheinyl transferases, Chem. Biol. 3
(1996) 923^936.
[10] C.T. Walsh, A.M. Gehring, P.H. Weinreb, L.E.N. Quadri, R.S. Flu-
gel, Post-translational modi¢cation of polyketide and nonribosomal
peptide synthases, Curr. Opin. Chem. Biol. 1 (1997) 309^315.
[11] H.P. Stuible, S. Meier, C. Wagner, E. Hannappel, E. Schweizer, A
novel phosphopantetheine :protein transferase activating yeast mito-
chondrial acyl carrier protein, J. Biol. Chem. 273 (1998) 22334^
22339.
[12] F. Fichtlscherer, C. Wellein, M. Mittag, E. Schweizer, A novel func-
tion of yeast fatty acid synthase: subunit K is capable of self-pante-
theinylation, Eur. J. Biochem. 267 (2000) 2666^2671.
[13] H.J. Schuller, B. Fortsch, B. Rautenstrauss, D.H. Wolf, E. Schweizer,
Di¡erential proteolytic sensitivity of yeast fatty acid synthetase sub-
units alpha and beta contributing to a balanced ratio of both fatty
acid synthetase components, Eur. J. Biochem. 203 (1992) 607^614.
[14] R. Schorr, M. Mittag, M. Mu«ller, E. Schweizer, Di¡erential activities
and intramolecular location of fatty acid synthase and 6-methylsaly-
cilic acid synthase component enzymes, J. Plant Physiol. 143 (1994)
407^415.
[15] C.W. Borell, J.K. Bhattacharjee, Cloning and biochemical character-
ization of LYS5 gene of Saccharomyces cerevisiae, Curr. Genet. 13
(1988) 299^304.
[16] R.H. Lambalot, C.T. Walsh, Cloning, overproduction, and charac-
terization of the Escherichia coli holo-acyl carrier protein synthase,
J. Biol. Chem. 270 (1995) 24658^24661.
[17] R.S. Flugel, Y. Hwangbo, R.H. Lambalot, J.E. Cronan Jr., C.T.
Walsh, Holo-(acyl carrier protein) synthase and phosphopantetheinyl
transfer in Escherichia coli, J. Biol. Chem. 275 (2000) 959^968.
[18] P.E. Coderre, C.F. Earhart, The entD gene of the Escherichia coli
K12 enterobactin gene cluster, J. Gen. Microbiol. 135 (1989) 3043^
3055.
[19] M.M. Nakano, M.A. Marahiel, P. Zuber, Identi¢cation of a genetic
locus required for biosynthesis of the lipopeptide antibiotic surfactin
in Bacillus subtilis, J. Bacteriol. 170 (1988) 5662^5668.
CHBIOL 112 5-7-01 Cyaan Magenta Geel Zwart
736 Chemistry & Biology 8/7 (2001) 725^738
[20] M.M. Nakano, N. Corbell, J. Besson, P. Zuber, Isolation and char-
acterization of sfp : a gene that functions in the production of the
lipopeptide biosurfactant, surfactin, in Bacillus subtilis, Mol. Gen.
Genet. 232 (1992) 313^321.
[21] S. Borchert, T. Stachelhaus, M.A. Marahiel, Induction of surfactin
production in Bacillus subtilis by gsp, a gene located upstream of the
gramicidin S operon in Bacillus brevis, J. Bacteriol. 176 (1994) 2458^
2462.
[22] T. Brautaset, O.N. Sekurova, H. Sletta, T.E. Ellingsen, A.R. Strom,
S. Valla, S.B. Zotchev, Biosynthesis of the polyene antifungal anti-
biotic nystatin in Streptomyces noursei ATCC 11455: analysis of the
gene cluster and deduction of the biosynthetic pathway, Chem. Biol.
7 (2000) 395^403.
[23] L. Westrich, S. Domann, B. Faust, D. Bedford, D.A. Hopwood, A.
Bechthold, Cloning and characterization of a gene cluster from Strep-
tomyces cyanogenus S136 probably involved in landomycin biosyn-
thesis, FEMS Microbiol. Lett. 170 (1999) 381^387.
[24] L.E.N. Quadri, J. Sello, T.A. Keating, P.H. Weinreb, C.T. Walsh,
Identi¢cation of a Mycobacterium tuberculosis gene cluster encoding
the biosynthetic enzymes for assembly of the virulence-conferring
siderophore mycobactin, Chem. Biol. 5 (1998) 631^645.
[25] J. Ku, R.G. Mirmira, L. Liu, D.V. Santi, Expression of a functional
non-ribosomal peptide synthetase module in Escherichia coli by coex-
pression with a phosphopantetheinyl transferase, Chem. Biol. 4
(1997) 203^207.
[26] J.T. Kealey, L. Liu, D.V. Santi, M.C. Betlach, P.J. Barr, Production
of a polyketide natural product in nonpolyketide-producing prokary-
otic and eukaryotic hosts, Proc. Natl. Acad. Sci. USA 95 (1998) 505^
509.
[27] P.J. Belshaw, C.T. Walsh, T. Stachelhaus, Aminoacyl-CoAs as
probes of condensation domain selectivity in nonribosomal peptide
synthesis, Science 284 (1999) 486^489.
[28] B. Shen, L. Du, C. Sanchez, M. Chen, D.J. Edwards, Bleomycin
biosynthesis in Streptomyces verticillus ATCC15003: a model of hy-
brid peptide and polyketide biosynthesis, Bioorg. Chem. 27 (1999)
155^171.
[29] L. Du, B. Shen, Identi¢cation of a type II peptidyl carrier protein
from the bleomycin producer Streptomyces verticillus ATCC 15003,
Chem. Biol. 6 (1999) 507^517.
[30] L. Du, C. Sa¤nchez, M. Chen, D.J. Edwards, B. Shen, The biosyn-
thetic gene cluster for the antitumor drug bleomycin from Strepto-
myces verticillus ATCC15003 supporting functional interactions be-
tween nonribosomal peptide synthetases and a polyketide synthase,
Chem. Biol. 7 (2000) 623^642.
[31] L. Du, M. Chen, C. Sa¤nchez, B. Shen, An oxidation domain in the
BlmIII non-ribosomal peptide synthetase probably catalyzing thia-
zole formation in the biosynthesis of the anti-tumor drug bleomycin
in Streptomyces verticillus, FEMS Microbiol. Lett. 289 (2000) 171^
175.
[32] L. Du, C. Sa¤nchez, B. Shen, Hybrid peptide-polyketide natural prod-
ucts: biosynthesis and prospects towards engineering novel mole-
cules, Metab. Eng. 3 (2001) 78^95.
[33] Y. Li, D.C. Dosch, W.R. Strohl, H.G. Floss, Nucleotide sequence
and transcriptional analysis of the nosiheptide-resistance gene from
Streptomyces actuosus, Gene 91 (1990) 9^17.
[34] S.T. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris,
S.V. Gordon, K. Eigimeier, G. Gas, C.E. Barry III, F. Tekia, K.
Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R.
Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T.
Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K.
Oliver, J. Osborne, M.A. Quail, M.-A. Rajandream, J. Rogers, S.
Rutter, K. Seeger, J. Skelton, R. Squares, S. Swuares, J.-E. Sulston,
K. Taylor, S. Whitehead, B.G. Barrell, Deciphering the biology of
Mycobacterium tuberculosis from the complete genome sequence, Na-
ture 393 (1998) 537^544.
[35] H. Mori, T. Shibasaki, K. Yano, A. Ozaki, Puri¢cation and cloning
of a proline 3-hydroxylase, a novel enzyme which hydroxylates free
L-proline to cis-3-hydroxy-L-proline, J. Bacteriol. 179 (1997) 5677^
5683.
[36] T.M. Rose, E.R. Schltz, J.G. Heniko¡, S. Pietrokovski, C.M. McCal-
lum, S. Heniko¡, Consensus-degenerate hybrid oligonucleotide prim-
ers for ampli¢cation of distantly related sequences, Nucleic Acids
Res. 26 (1998) 1628^1685.
[37] M.J. Bibb, P.R. Findlay, M.W. Johnson, The relationship between
base composition and codon usage in bacterial genes and its use for
the simple and reliable identi¢cation of protein-coding sequences,
Gene 30 (1984) 157^166.
[38] F. Wright, M.J. Bibb, Codon usage in the G+C-rich Streptomyces
genome, Gene 113 (1992) 55^65.
[39] F.R. Blattner, G. Plunkett III, C.A. Bloch, N.T. Perna, V. Burland,
M. Riley, J. Collado-Vides, J.D. Glasner, C.K. Rode, G.F. Mayhew,
J. Gregor, N.W. Davis, H.A. Kirkpatrick, M.A. Goeden, D.J. Rose,
B. Mau, Y. Shao, The complete genome sequence of Escherichia coli
K-12, Science 277 (1997) 1453^1474.
[40] N.S. Scrutton, A. Berry, R.N. Perham, Redesign of the coenzyme
speci¢city of a dehydrogenase by protein engineering, Nature 343
(1990) 38^43.
[41] B. Shen, R.G. Summers, H. Gramajo, M.J. Bibb, C.R. Hutchinson,
Puri¢cation and characterization of the acyl carrier protein of the
Streptomyces glaucescens tetracenomycin C polyketide synthase,
J. Bacteriol. 174 (1992) 3818^3821.
[42] W. Liu, B. Shen, Genes for production of the enediyne antitumor
antibiotic C-1027 in Streptomyces globisporus are clustered with the
cagA gene that encodes the C-1027 apoprotein, Antimicrob. Agents
Chermother. 44 (2000) 382^392.
[43] D. Konz, A. Klens, K. Schorgendorfer, M.A. Marahiel, The bacitra-
cin biosynthesis operon of Bacillus licheniformis ATCC 10716: mo-
lecular characterization of three multi-modular peptide synthetases,
Chem. Biol. 4 (1997) 927^937.
[44] T. Stachelhaus, A. Hu«ser, M.A. Marahiel, Biochemical characteriza-
tion of peptidyl carrier protein (PCP), the thiolation domain of multi-
functional peptide synthetases, Chem. Biol. 3 (1996) 913^921.
[45] A.M. Gehring, R.H. Lambalot, K.W. Vogel, D.G. Drueckhammer,
C.T. Walsh, Ability of Streptomyces spp. acyl carrier proteins and
coenzyme A analogs to serve as substrates in vitro for E. coli holo-
ACP synthase, Chem. Biol. 4 (1997) 17^24.
[46] L.E.N. Quadri, P.W. Weinreb, M. Lei, M.M. Nakano, P. Zuber,
C.T. Walsh, Characterization of Sfp, a Bacillus subtilis phosphopan-
tetheinyl transferase for peptidyl carrier protein domains in peptide
synthetases, Biochemistry 37 (1998) 1585^1595.
[47] M. Hara, K. Asano, I. Kawamoto, T. Takiguchi, S. Katsumata, K.-I.
Takahashi, H. Nakano, Leinamycin, a new antitumor antibiotic from
Streptomyces producing organism, fermentation and isolation,
J. Antibiot. 42 (1989) 1768^1774.
[48] U. Gra«fe, H. Kluge, R. Thiericke, Biogenetic studies on oxazolomy-
cin, a metabolite of Streptomyces albus (strain JA 3453), Liebigs Ann.
Chem. (1992) 429^432.
[49] H.-J. Kown, W.C. Smith, L. Xiang, B. Shen, Cloning and heterolo-
gous expression of the macrotetrolide biosynthetic gene cluster re-
vealed a novel polyketide synthase that lacks an acyl carrier protein,
J. Am. Chem. Soc. 123 (2001) 3385^3386.
[50] K. Reuter, M.R. Mo¢d, M.A. Marahiel, R. Ficner, Crystal structure
of the surfactin synthetase-activating enzyme Sfp: a prototype of the
4P-phosphopantetheinyl transferase superfamily, EMBO J. 18 (1999)
6823^6831.
[51] K.D. Parris, L. Lin, A. Tam, R. Mathew, J. Hixon, M. Stahl, C.C.
Fritz, J. Seehra, W.S. Somers, Crystal structures of substrate binding
to Bacillus subtilis holo-(acyl carrier protein) synthase reveal a novel
trimeric arrangement of molecules resulting in three active sites,
Structure 8 (2000) 883^895.
[52] K.A. McAllister, R.B. Peery, T.I. Meier, A.S. Fischl, G. Zhao, Bio-
chemical and molecular analyses of the Streptococcus pneumoniae
acyl carrier protein synthase, an enzyme essential for fatty acid bio-
synthesis, J. Biol. Chem. 275 (2000) 30864^30872.
CHBIOL 112 5-7-01 Cyaan Magenta Geel Zwart
Research Paper A phosphopantetheinyl transferase from Streptomyces verticillus C. Sa¤nchez et al. 737
[53] L. Du, B. Shen, Biosynthesis of hybrid peptide-polyketide natural
products, Curr. Opin. Drug Discov. Dev. 4 (2001) 215^228.
[54] J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning: A Lab-
oratory Manual, 2nd edn., Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY, 1989.
[55] T. Kieser, M.J. Bibb, M.J. Buttner, K.F. Chater, D.A. Hopwood,
Practical Streptomyces Genetics, The John Innes Foundation, Nor-
wich, 2000.
[56] V.B. Rajgarhia, W.R. Strohl, Minimal Streptomyces sp. Strain C5
daunorubicin polyketide biosynthesis genes required for aklanonic
acid biosynthesis, J. Bacteriol. 179 (1997) 2690^2696.
CHBIOL 112 5-7-01 Cyaan Magenta Geel Zwart
738 Chemistry & Biology 8/7 (2001) 725^738
